GSK plc 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-09-27 06:01 am Unchanged | 2021-08-16 | 13G | Fulcrum Therapeutics, Inc. FULC | GSK plc | 1,785,714 4.500% | 0 (Unchanged) | Filing |